Literature DB >> 10843824

Feasibility and prognostic value of dobutamine-atropine stress echocardiography early in unstable angina.

M Sitges1, C Paré, M Azqueta, X Bosch, F Miranda-Guardiola, M Velamazán, J Magriñá, G Sanz.   

Abstract

BACKGROUND AND AIM: Because unstable angina has always been considered a contraindication for dobutamine-atropine stress echocardiography (DSE), the role of dobutamine-atropine stress echocardiography in unstable angina is unknown. Our aim was to assess the safety and prognostic value of dobutamine-atropine stress echocardiography in unstable angina.
METHODS: One hundred and thirty-two patients were studied (mean age 64+/-12 years, 29 women). Dobutamine-atropine stress echocardiography was performed on the third day after hospital admission. End-points were unstable angina, myocardial infarction or cardiac death at 1 year follow-up.
RESULTS: No major complications occurred during dobutamine-atropine stress echocardiography. Ninety-six (78%) patients were on beta-blocker therapy during the test; mean maximum heart rate achieved was 106+/-23 beats x min(-1). Nine of the 21 patients (43%) with a positive dobutamine-atropine stress echocardiography presented cardiac events during follow-up: two patients died, one had a myocardial infarction and six had recurrent class III-IV angina. Among 80 patients with negative dobutamine-atropine stress echocardiography, one (1%) had myocardial infarction and six patients (7.5%) had recurrent angina. Event-free survival after 1 year for patients with a negative dobutamine-atropine stress echocardiography for ischaemia was 91% compared to 57% for those with a positive dobutamine-atropine stress echocardiography (P<0. 0001). Left ventricular dysfunction (P=0.01), prior myocardial infarction (P=0.03) and a positive dobutamine-atropine stress echocardiography (P=0.004) were independent predictors of cardiac events during follow-up.
CONCLUSIONS: Dobutamine-atropine stress echocardiography is safe in unstable angina if it is performed when patients remain asymptomatic for at least 48 h. A negative dobutamine-atropine stress echocardiogram for ischaemia predicts a good prognosis in medically treated patients with unstable angina and may allow their early discharge from hospital. Good prognostic information was obtained despite the use of beta-blockers and low heart rates during dobutamine-atropine stress echocardiography. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843824     DOI: 10.1053/euhj.1999.1856

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  3 in total

1.  Safety and feasibility of atropine added to submaximal exercise stress testing with Tl-201 SPECT for the diagnosis of myocardial ischemia.

Authors:  Sanjay K Prasad; Dudley J Pennell
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  Addition of atropine to submaximal exercise stress testing in patients evaluated for suspected ischaemia with SPECT imaging: a randomized, placebo-controlled trial.

Authors:  Fiore Manganelli; Marco Spadafora; Paola Varrella; Giuseppina Peluso; Rosario Sauro; Emilio Di Lorenzo; Giuseppe Rosato; Stefania Daniele; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02       Impact factor: 9.236

3.  Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation.

Authors:  M Bountioukos; A Elhendy; R T van Domburg; A F L Schinkel; J J Bax; B J Krenning; E Biagini; V Rizzello; M L Simoons; D Poldermans
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.